Instructions for authors

A manuscript submitted to the Journal must constitute a unique piece of work that is not previously published or under consideration for publication, in part or whole, elsewhere. 

GUIDELINES FOR SUBMISSION

Submissions should preferably be produced using Microsoft Word, although other formats will be considered. Submissions should be anonymized.
The submission process requires three discreet documents:

  1. Cover Letter
  2. Title Page
  3. Manuscript (including Abstract, Tables and Figures)

Please ensure that the names and contact details of all authors are entered on the online submission system.

Cover Letter

This should be written by the corresponding author and must contain the following:

  1. The type of manuscript submission (Original Article, Review Article, etc).
  2. A sentence or two on the subject of the study.
  3. Confirmation that the study is not under consideration for publication by another journal.
  4. Confirmation that all of the authors have made a substantial contribution to the manuscript and that they have seen and approved the submission draft.
  5. A conflict-of-interest statement regarding the authors. Where there is none, this should be clearly stated. More information about the Journal's publication ethics can be found on the Ethics and Policies page.
  6. A clear statement that the authors follow the ethical guidelines as stated on the Journal's Ethics and Policies page.

Title Page

This should consist of the following:

  • Title: This should be concise and reflect the type and purpose of the study.
  • Authors: These should be listed in order for publication, with first name, initials and surname.
  • Affiliations: The institution(s) that the authors are affiliated with should be listed. Ensure that sufficient information is included to identify the authors (full addresses are not required).
  • Corresponding Author: This individual should be clearly identified, along with one full institutional address and email address.
  • Presentation: The meeting where any of the submitted data was presented should be listed.
  • Disclosure: To disclose any official information. 
  • Acknowledgements (Optional): Any acknowledgements that you would like to include. 
  • Conflicts of Interest (Compulsory): A conflict-of-interest statement regarding the authors. Where there is none, this should be clearly stated. 
  • Funding Declaration (Compulsory): Any grant funding should be listed or it should be noted if no grant funds were used.
  • Author Contributions (Optional): All authors are expected to have substantially contributed to the study and manuscript writing (see Authorship criteria).

Main Body

This should consist of text in 12 pts, double spaced with a justified margin, written in US English. While each article type has specified headings, the use of sub-headings is encouraged to aid clarity. These should be formatted as follows:

Main Heading BOLD, FULL CAPITALS
Sub-Heading  Bold and Italicized, Title Case
Sub-sub-heading  Italicized, sentence case

Abstract
The abstract should be a maximum of 250 words and consist of the following headings (but see specific manuscript types below for exceptions):

  • Background
  • Methods
  • Results
  • Conclusions

Keywords
Three to six appropriate keywords should be included.

References

References should follow the Vancouver Style and should be noted in the text numerically in sequence within the text, using square brackets, e.g.: [1] or [1,2] or [1–3].

Example references:

  • Stannard W, Rutman A, Wallis C, O'Callaghan C. Central microtubular agenesis causing primary ciliary dyskinesia. Am J Respir Crit Care Med. 2004;169:634–7.
  • Tang AL, Diven C, Zangbar B, et al. The elimination of anastomosis in open trauma vascular reconstruction. J Trauma Acute Care Surg. 2015; In Press. doi: XXXXXXXXXX.
  • Rasmussen TE, Tai NRM. Rich’s Vascular Trauma. 3rd ed. Philidelphia: Elsevier; 2015.
  • Thamm DH. Miscellaneous tumors. In: Withrow S, Vail D, editors. Small Animal Clinical Oncology. 5th ed. St. Louis: Elsevier; 2013. pp. 679–88.

Where there are more than six authors, the first three should be included followed by et al. 

Figures/Tables

All figures/tables must be cited within the text, presented as Figure 1, Figure 2a,b, Figures 1 and 2, and Table 1.

Figure captions should be styled as follows.

Figure 1 Title of figure.
Details of figure described below. (a) First sub item. (b) Second sub-item.

Table captions are styled similarly.

Supplementary Digital Content

Where manuscripts would benefit from additional content (datasets, images, video) that does not necessarily need to be included in the published article, supplementary digital content (SDC) can be hosted. This includes, but is not limited to, tables, figures, or video. Authors should include in their cover letter a description of this content and its purpose.

All supplementary digital content should be cited within the text, presented as e.g. Supplementary Video 1, Supplementary Dataset 1, Supplementary Image 1 etc.

TYPES OF ARTICLES

All of the following article types are peer reviewed.

Original Articles

  • This is a report of a formal basic science or clinical research study.
  • Manuscripts reporting unique scientific studies should be no longer than 5000 words. They should consist of the following sections:

    Introduction    : This should concisely present the background to the problem that the study hopes to answer. A hypothesis should be clearly stated.
    Methods: This section should be suitably detailed to permit replication of the study. The regulatory permissions for the study should also be detailed, e.g. Institutional Review Board, ethical committee etc, including a protocol/registration number. Where animal research has been undertaken, the institutional animal care and use guidelines that have been followed should be clearly stated.
    Results: These should involve the reporting of the salient positive and negative findings of the study in clear language. The use of images, figures and tables are encouraged, of which the data should not be duplicated in the prose. There is no maximum number of figures or tables, but these should be appropriate to the study. Numerical results and P values should be reported to three decimal places.
    Discussion: This should place the reported study findings in the context of the literature. Limitations and future direction should also be discussed. Authors must be careful to ensure that conclusions are not overstated and are supported by data.

  • They should contain a structured abstract with a maximum of 250 words. 

Editorials

  • Short, focused Editorials on an important aspect of endovascular hemorrhage control are welcomed. These should endeavor to bring attention to an important topic, or accompany an article published within the Journal. The latter will be invited by the Editor. 
  • Submitted manuscripts should be no longer than 1500 words.
  • Abstracts are not included. 

Narrative Reviews

  • This style of article can afford the author considerable latitude in examining a pertinent topic in endovascular hemorrhage control. The literature should be examined objectively and presented to the reader in the context of current understanding. The author should be able to synthesize a narrative, which leaves the reader with a good understanding of an emerging or controversial topic. The author is welcome (and encouraged) to express an opinion, but where this is the case, it should be clearly stated.
  • The submitted manuscript should be no longer than 5000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends).
  • There is no formal structure; however, the use of logical headings/sub-headings is important to enable readers to follow the article easily. 
  • The abstract should also be unstructured and be a maximum of 150 words. 

Systemic Reviews and Meta-Analyses

  • Where there is a topic within the subject area of endovascular hemorrhage control that has a substantial evidence base, a Systematic Review with/without a Meta-Analysis is considered more appropriate than a narrative review article. These articles should follow the methodology established by PRISMA. The overall aim is to provide a pooled analysis that enables firm conclusions to be drawn on a particular subject. 
  • Submitted manuscripts should be no longer than 5000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends).
  • Authors should include a PRISMA checklist in their submission. 
  • The abstract should be no longer than 250 words. 

Tips and Techniques

  • In the evolving world of endovascular hemorrhage control, the advice and opinion of actively practicing clinicians is of great importance. Both solicited and unsolicited submissions are reviewed, both on major and minor components of endovascular techniques. This can be presented in the context of “evidence” or just as an opinion. The use of quality images and diagrams is encouraged. This type of article permits the author to write from experience, rather than from the published literature. Articles explaining how to approach certain problems or how to accomplish certain maneuvers are welcomed.
  • The submitted manuscript should be no longer than 1500 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends).
  • The abstract should be unstructured and be a maximum of 150 words. 

Images of Interest

  • The Journal accepts images of interest accompanied by a short commentary. The aim of this section is to demonstrate and illustrate an educational message, rather than just to demonstrate dramatic pathology. Images can be submitted as a multi-panel with a series of scans/photographs in order to support the message presented in the narrative.  
  • The submitted manuscript should be no longer than 250 words for the main body of the text, references excluded.
  • Abstracts are not included. 

Case Reports

  • These are short case reports including current literature reviews. 
  • The submitted manuscript should be no longer than 2000 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends).
  • An abstract can be included (under 150 words) but is not compulsory. 

Letters to the Editor

  • Letters to the Editor that comment on anything within the Journal can be submitted for publication.
  • Abstracts are not included.

EVTM-ST Section

  • The EVTM-ST Section will be a section of each JEVTM edition geared towards residents/fellows and education. The editors will invite one trainee to submit an interesting case report, and invite a reviewer to review and add a brief editorial. The editors should not be authors nor reviewers.
    The components of the section will include a standard case report presentation with figures of CT or angio or anything interesting and pertinent. The discussion should finish with a "what I learned" summary/bullet points for education purposes. The brief editorial by the reviewer is the final paragraph.
  • The submissions should be a maximum of 1500 words for the main body of the text (from introduction to conclusion, and excluding abstract, references, tables and legends).
  • An abstract can be included (under 150 words) but is not compulsory.

Conference Proceedings

  • Where a conference is affiliated to the Journal, the proceedings will be published as agreed by the Editorial Board.

 

SUPPORT FOR LANGUAGE AND ARTICLE CONTENT

The aim of the Journal, in addition to the dissemination of peer-reviewed evidence, is to support English-second-language authors and early career scientists. Provided that a submitted manuscript has good scientific merit, the Journal is able to provide a free language editing service. Furthermore, where article content would benefit from high-quality figures, artwork can be commissioned to support the publication. 

AFTER ACCEPTANCE

Once your article has been accepted and undergone peer review, it will be processed and you will receive the proofs.

COPYRIGHT AND LICENSING
Authors contributing to the JEVTM agree to publish their articles under a Creative Commons CC BY 4.0 License, allowing third parties to read and download, and to copy and disseminate for non-commercial purposes. Articles will be published immediately after the final corrections of the master proof have been made. Authors retain copyright of their work and grant first publication rights to the JEVTM.

PROOFREADING

The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title, and authorship, are not allowed without the approval of the Editor-in-chief.

After online publication, further changes can only be made in the form of an Erratum, which will be hyperlinked to the article.

ONLINE FIRST

The article will be published online after receipt of the corrected proofs. This is the official first publication citable with the DOI. After release of the printed version, the paper can also be cited by issue and page numbers.

ACCESS

All articles in the JEVTM are open access and upon acceptance are immediately and permanently free for everyone to read and download.